RARE — ULTRAGENYX PHARMACEUTICAL IN

Ownership history in Quantbot Technologies LP  ·  14 quarters on record

This page tracks every 13F SEC filing in which Quantbot Technologies LP reported a position in ULTRAGENYX PHARMACEUTICAL IN (RARE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2021 Q1)
Avg. % of fund
0.02%
First filed
2015 Q1
Last filed
2025 Q3
Quarters held
14
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 6,251 +6,235 +38968.8% 0.01% $188K $30.08
2024 Q4 REDUCED 16 -6,219 -99.7% 0.00% $673 $42.07
2022 Q4 ADDED 6,235 +2,087 +50.3% 0.02% $289K $46.33
2021 Q2 REDUCED 4,148 -898 -17.8% 0.03% $395K $95.35
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RARE price (monthly, adj. close)

Other funds also holding RARE

As of 2025 Q4 — sorted by position size

GordonMD Global Investments LP 5.43% B Group, Inc. 2.29% GREAT POINT PARTNERS LLC 3Y 7Y 2.24% Stonepine Capital Management, LLC 3Y 7Y 1.68% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.56% Privium Fund Management B.V. 3Y 1.51% Rock Springs Capital Management LP 3Y 7Y 1.49% Palo Alto Investors LP 3Y 7Y 1.48% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.34% Krensavage Asset Management, LLC 3Y 7Y 1.22%
← Back to Quantbot Technologies LP Holdings